Skip to content

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00691327
Enrollment
84329
Registered
2008-06-05
Start date
1997-12-31
Completion date
2012-12-31
Last updated
2014-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction

Keywords

Revision of augmentation or reconstruction

Brief summary

Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.

Interventions

Sponsors

Allergan Medical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Females of any age for which breast reconstruction is considered appropriate (Patients under 18 years old require parental/legal guardian consent to participate. * Females seeking revision augmentation or revision reconstruction, where problems exist * Have any of the following conditions or situations present: * Post mastectomy surgical removal of the breast for cancer or other disease; * Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity; * Severe ptosis requiring reconstruction; * Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity. * Adequate tissue available to cover implants. * Saline-filled implants are not an appropriate choice.

Exclusion criteria

* Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy. * Existing carcinoma of the breast, without mastectomy. * Abscess of infection in the body at the time of enrollment. * Pregnant or nursing. * Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability. * Show tissue characteristics which are clinically incompatible with mammaplasty. * Have, or under treatment for any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk. * Are not willing to undergo further surgery for revision, if medically required. * Diagnosis of lupus or scleroderma.

Design outcomes

Primary

MeasureTime frameDescription
Local Complications5 yearsBy patient risk of complications occurring in at least 5% of patients in 1 or more cohorts

Secondary

MeasureTime frameDescription
Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale5 yearsSatisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied

Countries

United States

Participant flow

Participants by arm

ArmCount
Reconstruction
Women who have undergone Breast Reconstruction
45,055
Revision
Women who have undergone Revision of a Breast Augmentation or Reconstruction
39,274
Total84,329

Baseline characteristics

CharacteristicReconstructionRevisionTotal
Age, Customized
<=17 years
115 participants4 participants119 participants
Age, Customized
>=70 years
1065 participants1039 participants2104 participants
Age, Customized
Between 18 and 69 years
43304 participants37612 participants80916 participants
Age, Customized
Not provided
571 participants619 participants1190 participants
Sex: Female, Male
Female
45055 Participants39274 Participants84329 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 45,0550 / 39,274
serious
Total, serious adverse events
0 / 45,0550 / 39,274

Outcome results

Primary

Local Complications

By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts

Time frame: 5 years

Population: All enrolled patients

ArmMeasureGroupValue (NUMBER)
ReconstructionLocal ComplicationsCapsular Contracture15.0 Percentage by Patient
ReconstructionLocal ComplicationsAsymmetry11.1 Percentage by Patient
ReconstructionLocal ComplicationsImplant Palpability/Visibility7.1 Percentage by Patient
ReconstructionLocal ComplicationsImplant Malposition6.5 Percentage by Patient
ReconstructionLocal ComplicationsWrinkling5.6 Percentage by Patient
ReconstructionLocal ComplicationsBreast Pain5.2 Percentage by Patient
RevisionLocal ComplicationsWrinkling8.9 Percentage by Patient
RevisionLocal ComplicationsCapsular Contracture21.6 Percentage by Patient
RevisionLocal ComplicationsImplant Malposition7.1 Percentage by Patient
RevisionLocal ComplicationsAsymmetry10.7 Percentage by Patient
RevisionLocal ComplicationsBreast Pain6.6 Percentage by Patient
RevisionLocal ComplicationsImplant Palpability/Visibility11.4 Percentage by Patient
Secondary

Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale

Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied

Time frame: 5 years

Population: All patients who had a breast implant satisfaction rating

ArmMeasureGroupValue (MEAN)Dispersion
ReconstructionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePhysician Satisfaction4.4 Units on a scaleStandard Deviation 0.9
ReconstructionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePatient Satisfaction4.4 Units on a scaleStandard Deviation 0.9
RevisionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePhysician Satisfaction4.3 Units on a scaleStandard Deviation 1
RevisionSatisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point ScalePatient Satisfaction4.3 Units on a scaleStandard Deviation 1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026